Esteve Pharmaceuticals SA - Company Profile
Powered by
All the data and insights you need on Esteve Pharmaceuticals SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Esteve Pharmaceuticals SA Strategy Report
- Understand Esteve Pharmaceuticals SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Esteve Pharmaceuticals SA patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
IL310950A | Application | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection | A61K31/5375; A61K31/5386; A61P21/00; A61P25/28 | April 01, 2024 |
AU2022346825A1 | Application | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection | A61K31/5375; A61K31/5386; A61P21/00; A61P25/28 | March 07, 2024 |
US11919926B2 | Grant | Method of treating hiv-1 infection utilizing a multiepitope t cell immunogen comprising gag, pol, vif, and nef epitopes | A61K2039/5256; A61K2039/53; A61K2039/545; A61K2039/57; A61K2039/575; A61K39/12; A61K39/21; C07K14/005; C07K2319/00; C07K2319/35; C12N2740/16022; C12N2740/16034; C12N2740/16122; C12N2740/16134; C12N2740/16222; C12N2740/16322; C12N7/00 | March 05, 2024 |
US20240059690A1 | Application | Pyrazolo[1,5-a]pyrimidine derivatives having multimodal activity against pain | A61P29/02; C07D487/04 | February 22, 2024 |
IL273751B2 | Grant | Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one | A61K31/5386; A61P29/00; C07B2200/13; C07D498/10 | February 01, 2024 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer